Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Gains from Investment Securities (2024 - 2025)

RenovoRx's Gains from Investment Securities history spans 2 years, with the latest figure at -$175000.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 24.89% year-over-year to -$175000.0; the TTM value through Jun 2025 reached $3.7 million, up 189.14%, while the annual FY2024 figure was $2.8 million, 263.69% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was -$175000.0 at RenovoRx, down from $3.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.7 million in Q2 2025 and bottomed at -$1.4 million in Q1 2024.